Patents
Patents for C07D 265 - Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms (11,132)
09/2010
09/30/2010WO2010111626A2 Poly (adp-ribose) polymerase (parp) inhibitors
09/30/2010WO2010108903A1 2,3-diaryl- or heteroaryl-substituted 1,1,1-trifluoro-2-hydroxypropyl compounds
09/30/2010US20100249404 Method for Carrying Out Chemical Reactions with the Aid of an Inductively Heated Heating Medium
09/30/2010US20100249135 Sulfonamides and their use as a medicament
09/30/2010US20100249124 2,3-diaryl- or heteroaryl-substituted 1,1,1-trifluoro-2-hydroxypropyl compounds
09/30/2010US20100249123 Novel benzamide derivatives as modulators of the follicle stimulating hormone
09/30/2010US20100249101 Malonamide derivatives with antithrombotic activity
09/30/2010CA2754176A1 2,3-diaryl- or heteroaryl-substituted 1,1,1-trifluoro-2-hydroxypropyl compounds
09/29/2010EP2233140A1 Bicyclic amides for enhancing glutamatergic synaptic responses
09/29/2010EP2231625A1 Thiazole and oxazole kinase inhibitors
09/29/2010EP1638928B1 N-alkynyl-2-(substituted aryloxy)alkylthioamide derivatives as fungicides
09/29/2010CN1821217B Process for producing trans-4-amino-1-cyclohexanecarboxylic acid derivative
09/29/2010CN101848900A Crystalline hydrate of betamimetika and use as medicament thereof
09/29/2010CN101845009A Structural carotenoid analogs for the inhibition and amelioration of disease
09/28/2010CA2407726C Sulfonated [8,9]benzophenoxazine dyes and the use of their labelled conjugates
09/28/2010CA2387016C Acrylamide derivatives as fab i inhibitors
09/23/2010WO2010107768A1 Bicyclic compounds as inhibitors of diacylglycerol acyltransferase
09/23/2010US20100240644 Morpholine derivative
09/23/2010US20100240622 Nitric oxide enhancing prostaglandin compounds, compositions and methods of use
09/23/2010CA2755253A1 Bicyclic compounds as inhibitors of diacylglycerol acyltransferase
09/22/2010EP2229590A1 Process of making 3-phenylimino-3h-phenothiazine or 3-phenylimino-3h-phenoxazine mediator
09/22/2010EP2229368A1 Cyclic urea inhibitors of 11beta-hydroxysteroid dehydrogenase 1
09/22/2010EP2229362A1 Piperazines as anti-obesity agents
09/21/2010US7799913 Carbonylbenzoxazine compounds for enhancing glutamatergic synaptic responses
09/21/2010US7799824 Quaternary salt CCR2 antagonists
09/16/2010WO2010103312A1 Hydroxymorpholiness and their use for the treatment of inflammatory disorders and pain
09/16/2010WO2010103064A1 Novel benzoxazinone derivatives useful for the treatment of cns disorders
09/16/2010WO2010056320A3 Pi3k/mtor kinase inhibitors
09/16/2010US20100234367 7-cycloalkylaminoquinolones as gsk-3 inhibitors
09/16/2010US20100234364 Ccr2 inhibitors and methods of use thereof
09/16/2010US20100234363 Heterocyclic derivative having inhibitory activity on type-i 11 data-hydroxysteroid dehydrogenase
09/16/2010US20100233279 Compositions And Methods Comprising Analogues Of Radicicol A
09/16/2010US20100233268 Powder formulations for inhalation containing enantiomerically pure beta-agonists
09/16/2010US20100230666 Amine-type polymeric compound, and light-emitting element comprising the same
09/15/2010EP1836150B1 Hydroxyphenol derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic uses thereof
09/15/2010CN101830862A Preparation method of high-heat-resistant, high-flame-resistant and low-cost phenolic benzoxazine resin
09/15/2010CN101830861A Preparation method of diphenyl ether supported benzoxazinyl resin
09/15/2010CN101830843A Substituted heterocyclic compound and synthetic method thereof
09/14/2010US7795471 Triethylamine was added dropwise to a solution of 2-methylpropane-2-sulfinyl chloride and methyl trans-4-amino-1-cyclohexane carboxylate p-toluenesulfonate in tetrahydrofuran solvent to obtain Methyl trans-4-(2-methylpropane-2-sulfonylamino)cyclohexanecarboxylate; hydrolysis; oxidation; intermediates
09/14/2010US7795425 by catalytic hydrogenation in the presence of a palladium catalyst, methanol and hydrogen gas preferably being conducted under basic conditions with acetic acid being added to the medium of reaction once the consumption of the hydrogen gas has ceased
09/14/2010US7795315 N-(2-amino-phenyl)-amide derivatives
09/14/2010US7795251 such as 3-[4-(tert-Butyl-dimethyl-silanyloxy)-phenyl]-7-hydroxy-3,4-dihydro-benzo[e][1,3]oxazin-2-one, inhibitors macrophage migration inhibitory factor isomerase activity; treatment of vision defects, ischemia, inflammatory, autoimmune, bone, nervous system, cardiovascular and gastrointestinal disorders
09/10/2010WO2010102212A2 Neurotrophin mimetics and uses thereof
09/10/2010WO2010101247A1 Cyclohexane derivative having npy y5 receptor antagonism
09/10/2010WO2010083441A3 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
09/10/2010CA2754570A1 Neurotrophin mimetics and uses thereof
09/09/2010US20100228026 Novel malonic acid sulfonamide derivative and pharmaceutical use thereof
09/09/2010US20100228025 Structured organic films having an added functionality
09/09/2010US20100228015 Prodrug derivatives of acids using alcohols with homotopic hydroxy groups and methods for their preparation and use
09/09/2010US20100227862 Diaza-spiro [4.5] decanes useful as pesticides
09/09/2010US20100224867 Electronic devices comprising structured organic films
09/08/2010EP2226325A1 Process for production of 4-(substituted phenyl)hexahydropyridoý2,1-c¨ý1,4¨oxazin-6-one
09/08/2010EP2225217A2 Morpholines as selective inhibitors of cytochrome p450 2a13
09/08/2010CN101006084B 4-arylmorpholin-3-one derivatives, their preparation and therapeutic use thereof
09/07/2010US7790724 c-fms kinase inhibitors
09/02/2010WO2010067078A8 3,6-disubstituted xanthylium salts
09/02/2010US20100222581 Novel isophthalates as beta-secretase inhibitors
09/02/2010US20100222580 Process For The Preparation Of Onium Alkylsulfates Having A Low Halide Content
09/02/2010US20100222579 Process for the Preparation of Delmopinol and Derivatives Thereof
09/02/2010US20100222578 Process for preparing acyl amide compounds
09/02/2010US20100222316 Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
09/02/2010US20100222303 Reverse-turn mimetics and method relating thereto
09/01/2010EP2223916A1 Morpholine derivatives as norepinephrine reuptake inhibitors
09/01/2010CN101817800A Novel medicaments for the treatment of chronic obstructive pulmonary diseases
08/2010
08/31/2010US7786297 micronized 5-(4,4-dimethyl-2-oxo-1,4-dihydro-2H-3,1-benzoxazin-6-yl)-1H-pyrrole-2-carbonitrile; progesterone receptor modulator; contraception, hormone replacement therapy, carcinomas, dysfunctional bleeding, uterine leiomyomata, endometriosis, polycystic ovary syndrome; storage stable
08/31/2010US7786121 such as 6-(4-ethoxy-phenyl)-2S-hydroxy-3R-[4-(3-methoxy-phenyl)-piperazine-1-carbonyl]-hexanoic acid hydroxyamide, used for the treatment or prophylaxis of arthritis in mammals
08/31/2010US7786117 used for treating glaucoma, inflammatory bowel disease and alopecia
08/31/2010US7786111 Medicaments for the treatment of chronic obstructive pulmonary disease
08/26/2010WO2010095602A1 Heterocyclic compound
08/26/2010US20100216796 N-hydroxy-naphthalene dicarboxamide and n-hydroxy-biphenyl-dicarboxamide compounds as histone deacetylase inhibitors
08/26/2010US20100216770 Inhibitors of the Interaction Between MDM2 and P53
08/25/2010EP2221304A1 Method for synthesizing intermediate compound for synthesizing a pharmaceutical agent
08/25/2010EP2221296A1 Fused indane compound
08/25/2010EP0883403B1 Method for treating sexual dysfunctions
08/25/2010CN101812033A Ibuprofen 2-arylmorpholine ethyl ester as well as preparation method and application thereof
08/24/2010US7781613 Inhibitor of hormone sensitive lipase; non-insulin dependent diabetes; antidiabetic agents; obesity
08/24/2010US7781461 Neuropeptide Y receptor antagonists comprising 4-(tert-butylsulfonylamino)-N-[5-(trifluoromethyl)pyridin-2-yl]cyclohexane-1-carboxamide and a pharmaceutically acceptable carrier, used for the treatment of obesity and as anorexigenic agents
08/24/2010US7781044 heat resistance; random access memory
08/24/2010CA2459752C 3-aminocarbonyl-substituted benzoylcyclohexanediones which can be used as herbicides
08/24/2010CA2431426C Flame-proofing agents
08/19/2010WO2010062536A3 Modified actinomycin-based nucleic acid stains and methods of their use
08/19/2010WO2010023685A3 Crystalline form of 2-(2-hydroxy phenyl)benz[e][1,3]oxazin-4-one, process for the same and use for producing 4-(3,5-bis(2-hydroxyphenyl)-1h-1,2,4-triazol-1-yl)benzoic acid
08/19/2010US20100210864 Process for the preparation of n-arylmorpholinones
08/19/2010US20100210837 Pactamycin biosynthetic gene cluster
08/19/2010US20100210653 Novel Compounds, Their Preparations and Use
08/19/2010US20100210636 Benzoxazinone derivative
08/19/2010US20100210635 Renin inhibitors
08/19/2010US20100210603 Novel sulfonamide inhibitors of aspartyl protease
08/19/2010US20100210495 Photo-labile pro-fragrance conjugates
08/19/2010US20100210452 Enantioselective reactions catalyzed by chiral triazolium salts
08/18/2010EP2218722A2 Process for producing benzoxazine derivative and production intermediate thereof
08/18/2010EP2217582A1 Crystalline hydrate of betamimetika and use as medicament thereof
08/18/2010EP1682523B1 Morpholine derivatives as norepinephrine reuptake inhibitors
08/18/2010CN101809006A Method of producing benzoxazinone-based compound
08/18/2010CN101809005A Fused bicyclic compound
08/18/2010CN101808616A Hair dye and hair dye composition
08/17/2010US7776853 Dietetics therapy; lipase inhibitor
08/12/2010US20100204234 17Beta-Hydroxysteroid Dehydrogenase Type 1 Inhibitors for the Treatment of Hormone-Related Diseases
08/12/2010US20100204218 Fused bicyclic compound
08/12/2010US20100204200 Inhibitors of cathepsin s
1 ... 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 ... 112